Suppr超能文献

COVID-19 肺炎后继发抗信号识别颗粒抗体阳性的纤维性间质性肺病。

COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease.

机构信息

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Department of Respiratory Physiology and Sleep Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Intern Med. 2023 May 1;62(9):1323-1328. doi: 10.2169/internalmedicine.8877-21. Epub 2023 Feb 8.

Abstract

Coronavirus disease 2019 (COVID-19) pneumonia is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is frequently accompanied by various sequelae. Interstitial lung diseases (ILDs) are observed in COVID-19 pneumonia patients after recovery, probably due to persistent inflammation in the lungs. We herein report a case of ILD with anti-signal recognition particle antibodies following severe COVID-19 pneumonia. The patient was diagnosed with ILD three months after COVID-19 pneumonia. Although the exact mechanism is unknown, the autoantibody-induced immune response might have been the pulmonary fibrosis trigger in this patient.

摘要

新型冠状病毒病(COVID-19)肺炎由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起,常伴有各种后遗症。COVID-19 肺炎患者在康复后观察到间质性肺疾病(ILD),可能是由于肺部持续炎症所致。本文报告了一例严重 COVID-19 肺炎后出现抗信号识别颗粒抗体的 ILD 病例。该患者在 COVID-19 肺炎后 3 个月被诊断为 ILD。尽管确切机制尚不清楚,但自身抗体诱导的免疫反应可能是该患者肺纤维化的触发因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d9/10208788/7f7bf8beab57/1349-7235-62-1323-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验